These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8920910)

  • 1. Integrin-specific tissue-type plasminogen activator engineered by introduction of the Arg-Gly-Asp sequence.
    Yamada T; Shimada Y; Kikuchi M
    Biochem Biophys Res Commun; 1996 Nov; 228(2):306-11. PubMed ID: 8920910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein loop grafting to construct a variant of tissue-type plasminogen activator that binds platelet integrin alpha IIb beta 3.
    Smith JW; Tachias K; Madison EL
    J Biol Chem; 1995 Dec; 270(51):30486-90. PubMed ID: 8530479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The exchange of Arg-Gly-Asp (RGD) and Arg-Tyr-Asp (RYD) binding sequences in a recombinant murine Fab fragment specific for the integrin alpha IIb beta 3 does not alter integrin recognition.
    Kunicki TJ; Ely KR; Kunicki TC; Tomiyama Y; Annis DS
    J Biol Chem; 1995 Jul; 270(28):16660-5. PubMed ID: 7542651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular basis for affinity modulation of Fab ligand binding to integrin alphaIIb beta3.
    Kunicki TJ; Annis DS; Deng YJ; Loftus JC; Shattil SJ
    J Biol Chem; 1996 Aug; 271(34):20315-21. PubMed ID: 8702765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3).
    Yamada T; Kidera A
    FEBS Lett; 1996 May; 387(1):11-15. PubMed ID: 8654558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions.
    Kauf AC; Hough SM; Bowditch RD
    Biochemistry; 2001 Aug; 40(31):9159-66. PubMed ID: 11478883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
    Mori K; Dwek RA; Downing AK; Opdenakker G; Rudd PM
    J Biol Chem; 1995 Feb; 270(7):3261-7. PubMed ID: 7852411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator.
    Kaneko M; Mimuro J; Matsuda M; Sakata Y
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1160-6. PubMed ID: 1908232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
    Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
    Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
    De Serrano VS; Castellino FJ
    Biochemistry; 1993 Apr; 32(14):3540-8. PubMed ID: 8385482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa.
    Kahn MJ; Kieber-Emmons T; Vilaire G; Murali R; Poncz M; Bennett JS
    Biochemistry; 1996 Nov; 35(45):14304-11. PubMed ID: 8916916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.